Skip to main navigation Skip to search Skip to main content

Correction to: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women (Nature Medicine, (2023), 29, 10, (2643-2655), 10.1038/s41591-023-02553-8)

  • EPIDEMIC Study Investigators
  • IRCCS Fondazione Ca'Granda – Ospedale Maggiore Policlinico - Milano
  • University of Gothenburg
  • University of Milan
  • Foundation for Liver Research
  • King's College London
  • University of Turin
  • Sahlgrenska University Hospital
  • Magna Græcia University
  • University of Palermo
  • Catholic University of the Sacred Heart
  • Fondazione Policlinico Universitario A. Gemelli IRCCS
  • Universita Campus Bio-Medico di Roma
  • University of Campania Luigi Vanvitelli
  • University of Udine
  • University of Eastern Finland

Research output: Contribution to journalComment/debate

Abstract

Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-023-02553-8, published online 25 September 2023. In the version of the article initially published, in Table 1, the “Transcriptomic cohort” section inadvertently duplicated data from the “Liver biopsy cohort” section above. The table has been amended to present the correct data in the HTML and PDF versions of the article.

Original languageEnglish
Pages (from-to)1212
Number of pages1
JournalNature Medicine
Volume30
Issue number4
DOIs
Publication statusPublished - Apr 2024
Externally publishedYes

ASJC Scopus subject areas

  • General Biochemistry,Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Correction to: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women (Nature Medicine, (2023), 29, 10, (2643-2655), 10.1038/s41591-023-02553-8)'. Together they form a unique fingerprint.

Cite this